Speaker Profile
Ph.D., Lead Application Scientist, VectorBuilder
Biography
Dr. Bai provides technical consultation on in vitro and in vivo gene delivery for research and clinical projects. He is experienced in design both viral (AAV, lentivirus, adenovirus) and non-viral (plasmid, in vitro transcribed mRNA, lipid nanoparticles) vectors.
Talk
Basics of IVT mRNA from Design to Therapy
In vitro transcribed (IVT) mRNA emerged as a promising therapeutic compound in the fight against the SARS-CoV-2 pandemic, offering distinct advantages over traditional tools like viral vectors. In this seminar, we will discuss the therapeutic applications of mRNA and producing potent mRNA with optimized design and chemically modified nucleotides.
Emerging Therapeutics Showcase:
VectorBuilder
VectorBuilder is a global leader in gene delivery technologies. As a trusted partner for thousands of labs and biotech/pharma companies across the globe, VectorBuilder offers a full spectrum of gene delivery solutions covering virtually all research and clinical needs from bench to bedside.
Session Abstract – PMWC 2025 Silicon Valley
The PMWC 2025 Emerging Therapeutics Showcase will provide a 15-30 minute time slot for selected companies and researchers in the CRISPR, Cell and Gene Therapy fields. Major advancements in safer cell- and gene-level editing technologies are bringing us closer toward cures for life-threatening disorders, from cancer to HIV to Huntington’s disease. Cell therapy, in which cellular material such as T cells capable of fighting cancer cells, is injected into a patient, has been demonstrated safe and effective. The popular new CRISPR tool that has been used to edit the genetic code of nearly any organism will have an enormous impact on human health. More than a dozen clinical trials employing CRISPR on human cells are already underway.
- Emerging Therapeutics/Cell Therapy
- Emerging Therapeutics/CVD
- Emerging Therapeutics/Gene Therapy
- Emerging Therapeutics/Immunotherapy
- Emerging Therapeutics/Radiation Therapy
